Consortium outlines clearer path to value-based drug pricing

The Robert J. Margolis Center for Health Policy at Duke University and a public-private consortium released a report outlining recommendations to overcome legal and regulatory barriers to value-based payment arrangements for medical products, including

Read the full 343 word article

User Sign In